Drugs / PDLLA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05913102 | Sep 2022 → Dec 2023 | skin pigmentation disorder | Jin Cheol Kim | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PDLLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05913102 ↗ |
| Modality | Other / unclassified | “irregular PDLLA particles” NCT05913102 ↗ |
| Route | Other | “injecting them through microneedling” NCT05913102 ↗ |